Nirsevimab 100MG/ML 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9DY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,590
Award facts
- Contract value 100% obligated
- $42,589.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $42,589.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Nirsevimab 100mg/mL (five units) on December 15, 2025, with an ultimate completion date of January 13, 2026. This delivery order is a child contract issued under AmerisourceBergen's $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as the company's primary vehicle for pharmaceutical and medical supply procurement across military healthcare systems. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal procurement requirements. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. Nirsevimab is a monoclonal antibody used for respiratory syncytial virus (RSV) prevention in infants and young children, representing a specialized healthcare commodity within the company's delivery scope. This delivery order exemplifies the routine pharmaceutical supply operations conducted under the company's larger IDC arrangement with the DLA, which enables flexible fulfillment of federal medical supply needs across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FW9DY?
SPE2DR26FW9DY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FW9DY worth?
The government has obligated $42,590 on SPE2DR26FW9DY.
Is contract SPE2DR26FW9DY an order under another contract?
Yes. SPE2DR26FW9DY is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9DY competed?
The extent of competition for SPE2DR26FW9DY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award